家族性慢性良性天疱疮研究进展

doi:10.35541/cjd.20240182

Abstract

Abstract: 【Abstract】 Familial benign chronic pemphigus （also known as Hailey-Hailey disease） is an autosomal dominant genetic disease characterized by epidermal acantholysis. Clinically, it manifests as erythema, blisters, erosions, exudation, and frequent secondary infections in intertriginous areas. To date, there is a dearth of effective treatment options available for this condition. This review summarizes recent advances in the research regarding the pathogenesis and treatment of Hailey-Hailey disease, aiming to serve as a valuable reference for future studies and clinical practice.

Key words: Pemphigus, benign familial, Genes, dominant, Therapeutics, Mutations in ATP2C1

Yuan Yongyong, Pan Meng. Advances in Hailey-Hailey Disease[J]. Chinese Journal of Dermatology,2025,e20240182. doi:10.35541/cjd.20240182

References ［39］

［1］	Hu Z, Bonifas JM, Beech J, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey⁃Hailey disease［J］. Nat Genet, 2000,24（1）:61⁃65. doi: 10.1038/71701.
［2］	Sudbrak R, Brown J, Dobson⁃Stone C, et al. Hailey⁃Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca（2+） pump［J］. Hum Mol Genet, 2000,9（7）:1131⁃1140. doi: 10.1093/hmg/9.7.1131.
［3］	Micaroni M, Giacchetti G, Plebani R, et al. ATP2C1 gene mutations in Hailey⁃Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking［J］. Cell Death Dis, 2016,7（6）:e2259. doi: 10.1038/cddis.2016.147.
［4］	Deng H, Xiao H. The role of the ATP2C1 gene in Hailey⁃Hailey disease［J］. Cell Mol Life Sci, 2017,74（20）:3687⁃3696. doi: 10.1007/s00018⁃017⁃2544⁃7.
［5］	Xiao Z, Liu ZG, Ou Yang XL, et al. Two novel variants and one previously reported variant in the ATP2C1 gene in Chinese Hailey⁃Hailey disease patients［J］. Mol Syndromol, 2021,12（3）:148⁃153. doi: 10.1159/000514282.
［6］	Konstantinou MP, Krasagakis K. Benign familial pemphigus （Hailey⁃Hailey disease）［M/OL］［2023⁃08⁃14］. In: StatPearls ［Internet］. Treasure Island （FL）: StatPearls, 2024. https://www.ncbi.nlm.nih.gov/books/NBK585136/.
［7］	Yang L, Zhang Q, Zhang S, et al. Generalized Hailey⁃Hailey disease: novel splice⁃site mutations of ATP2C1 gene in Chinese population and a literature review［J］. Mol Genet Genomic Med, 2021,9（2）:e1580. doi: 10.1002/mgg3.1580.
［8］	Wang Z, Wang Z, Sun L, et al. Whole exome sequencing improves mutation detection in Hailey⁃Hailey disease［J］. J Dermatol, 2021,48（7）:989⁃992. doi: 10.1111/1346⁃8138.15828.
［9］	Nellen RG, Steijlen PM, van Steensel MA, et al. Mendelian disorders of cornification caused by defects in intracellular calcium pumps: mutation update and database for variants in ATP2A2 and ATP2C1 associated with Darier disease and Hailey⁃Hailey disease［J］. Hum Mutat, 2017,38（4）:343⁃356. doi: 10. 1002/humu.23164.
［10］	Dobson⁃Stone C, Fairclough R, Dunne E, et al. Hailey⁃Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene［J］. J Invest Dermatol, 2002,118（2）:338⁃343. doi: 10.1046/j.0022⁃202x.2001.01675.x.
［11］	Cialfi S, Oliviero C, Ceccarelli S, et al. Complex multipathways alterations and oxidative stress are associated with Hailey⁃Hailey disease［J］. Br J Dermatol, 2010,162（3）:518⁃526. doi: 10.1111/j.1365⁃2133.2009.09500.x.
［12］	Manca S, Magrelli A, Cialfi S, et al. Oxidative stress activation of miR⁃125b is part of the molecular switch for Hailey⁃Hailey disease manifestation［J］. Exp Dermatol, 2011,20（11）:932⁃937. doi: 10.1111/j.1600⁃0625.2011.01359.x.
［13］	Zonfrilli A, Truglio F, Simeone A, et al. Loss of ATP2C1 function promotes trafficking and degradation of NOTCH1: Implications for Hailey⁃Hailey disease［J］. Exp Dermatol, 2023,32（6）:787⁃798. doi: 10.1111/exd.14769.
［14］	Arora H, Bray FN, Cervantes J, et al. Management of familial benign chronic pemphigus［J］. Clin Cosmet Investig Dermatol, 2016,9:281⁃290. doi: 10.2147/CCID.S89483.
［15］	Rogner DF, Lammer J, Zink A, et al. Darier and Hailey⁃Hailey disease: update 2021［J］. J Dtsch Dermatol Ges, 2021,19（10）:1478⁃1501. doi: 10.1111/ddg.14619.
［16］	Ben Lagha I, Ashack K, Khachemoune A. Hailey⁃Hailey disease: an update review with a focus on treatment data［J］. Am J Clin Dermatol, 2020,21（1）:49⁃68. doi: 10.1007/s40257⁃019⁃00477⁃z.
［17］	Reddy S, Brahmbhatt H. A Narrative review on the usage of surgical skin grafting, acitretin, and tacrolimus in the treatment of Hailey⁃Hailey disease［J］. Cureus, 2021,13（11）:e19704. doi: 10.7759/cureus.19704.
［18］	Pagliarello C, Paradisi A, Dianzani C, et al. Topical tacrolimus and 50% zinc oxide paste for Hailey⁃Hailey disease: less is more［J］. Acta Derm Venereol, 2012,92（4）:437⁃438. doi: 10.2340/00015555⁃1297.
［19］	Lowe N, Naumann M, Eadie N. Treatment of hyperhidrosis with Botox （onabotulinumtoxinA）: development, insights, and impact［J］. Medicine （Baltimore）, 2023,102（S1）:e32764. doi: 10.1097/MD.0000000000032764.
［20］	Saal R, Oldfield C, Bota J, et al. Double⁃blind, placebo⁃controlled study of onabotulinumtoxin A for the treatment of Hailey⁃Hailey disease［J］. J Drugs Dermatol, 2023,22（4）:339⁃343. doi: 10.36849/JDD.6857.
［21］	Zhang H, Tang K, Wang Y, et al. Botulinum toxin in treating Hailey⁃Hailey disease: a systematic review［J］. J Cosmet Dermatol, 2021,20（5）:1396⁃1402. doi: 10.1111/jocd.13963.
［22］	Falto⁃Aizpurua LA, Griffith RD, Yazdani Abyaneh MA, et al. Laser therapy for the treatment of Hailey⁃Hailey disease: a systematic review with focus on carbon dioxide laser resurfacing［J］. J Eur Acad Dermatol Venereol, 2015,29（6）:1045⁃1052. doi: 10.1111/jdv.12875.
［23］	Scarabello A, Pulvirenti C, Adebanjo G, et al. Photodynamic therapy with 5 aminolaevulinic acid: a promising therapeutic option for the treatment of Hailey⁃Hailey disease［J］. Photodiagnosis Photodyn Ther, 2022,38:102794. doi: 10.1016/j.pdpdt.2022.102794.
［24］	Wulf HC, Wiegell SR. Treatment of familial benign chronic pemphigus with superficial radiotherapy［J］. JAMA Dermatol, 2022,158（3）:283⁃287. doi: 10.1001/jamadermatol.2021.5491.
［25］	El⁃Samahy M, Mouffokes A, Badawy MM, et al. Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta⁃analysis of randomized controlled trials［J］. Arch Dermatol Res, 2023,315（8）:2215⁃2226. doi: 10.1007/s00403⁃023⁃02587⁃5.
［26］	Kaniszewska M, Rovner R, Arshanapalli A, et al. Oral glycopyrrolate for the treatment of Hailey⁃Hailey disease［J］. JAMA Dermatol, 2015,151（3）:328⁃329. doi: 10.1001/jamadermatol.2014.4578.
［27］	Bindernagel R, Kimmis BD, Liu D. Use of topical 2.4% glycopyrronium tosylate in familial benign pemphigus （Hailey⁃Hailey disease）［J］. Dermatol Online J, 2020,26（10）:13030/qt01j7n9qw ［pii］. doi: 10.5070/D32610050474.
［28］	Vyas HR, Shah SR, Patel HS, et al. Recalcitrant cases of Hailey⁃Hailey disease successfully managed with low⁃dose naltrexone［J］. Int J Dermatol, 2023,62（3）:e149⁃e151. doi: 10.1111/ijd. 16332.
［29］	Albers LN, Arbiser JL, Feldman RJ. Treatment of Hailey⁃Hailey disease with low⁃dose naltrexone［J］. JAMA Dermatol, 2017,153（10）:1018⁃1020. doi: 10.1001/jamadermatol.2017.2446.
［30］	Ibrahim O, Hogan SR, Vij A, et al. Low⁃dose naltrexone treatment of familial benign pemphigus （Hailey⁃Hailey disease）［J］. JAMA Dermatol, 2017,153（10）:1015⁃1017. doi: 10.1001/jamadermatol.2017.2445.
［31］	Alamon⁃Reig F, Serra⁃García L, Bosch⁃Amate X, et al. Dupilumab in Hailey⁃Hailey disease: a case series［J］. J Eur Acad Dermatol Venereol, 2022,36（10）:e776⁃e779. doi: 10.1111/jdv.18350.
［32］	Lyubchenko T, Collins HK, Vang KA, et al. SMOC1 and IL⁃4 and IL⁃13 cytokines interfere with Ca（2+） mobilization in primary human keratinocytes［J］. J Invest Dermatol, 2021,141（7）:1792⁃1801.e5. doi: 10.1016/j.jid.2020.12.026.
［33］	Liu W, Xue X, Li S. Treatment of Hailey⁃Hailey disease with biologics and small molecule inhibitors: a systematic review［J］. Clin Exp Dermatol, 2024,llae298. doi: 10.1093/ced/llae298.
［34］	Murphy L, Ch'en P, Song EJ. Refractory Hailey⁃Hailey disease cleared with upadacitinib［J］. JAAD Case Rep, 2023,41:64⁃67. doi: 10.1016/j.jdcr.2023.09.011.
［35］	Li Y, Jiang Y, Sun J. Improvement of Hailey⁃Hailey disease with abrocitinib［J］. Clin Exp Dermatol, 2023,48（5）:532⁃533. doi: 10.1093/ced/llad023.
［36］	Mansilla⁃Polo M, Abril⁃Pérez C, Navarro⁃Mira MÁ, et al. Recalcitrant Hailey⁃Hailey disease with satisfactory response to apremilast［J］. Actas Dermosifiliogr, 2023:S0001⁃7310（23）00490⁃00498 ［pii］. doi: 10.1016/j.ad.2023.05.022.
［37］	Barry R, Murray G, Hellen R, et al. Liraglutide, a GLP⁃1 agonist, as a new adjunct treatment in Hailey⁃Hailey disease: a case report［J］. Clin Exp Dermatol, 2024,49（4）:409⁃411. doi: 10. 1093/ced/llad429.
［38］	Stark GR, Cheon H, Wang Y. Responses to cytokines and interferons that depend upon JAKs and STATs［J］. Cold Spring Harb Perspect Biol, 2018,10（1）:a028555. doi: 10.1101/cshperspect.a028555.
［39］	Rogner D, Heimerl L, Heyer S, et al. Patients' perspective, quality of life and treatment goals in Hailey⁃Hailey disease: lessons learned from the german national registry［J］. J Eur Acad Dermatol Venereol, 2024,38（2）:419⁃429. doi: 10.1111/jdv. 19583.

[1]	Wang Di, Zhang Ruijun, Kang Yuying. Pathogenesis and treatment of seborrheic dermatitis [J]. Chinese Journal of Dermatology, 2025, 58(1): 89-92.
[2]	China Dermatologist Association. Guidelines for the management of chronic pruritus （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399.
[3]	Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118.
[4]	Chinese Society of Dermatology, China Dermatologist Association, Dermatology & Venereology Specialized Committee of Chinese Association of Integrative Medicine. Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(11): 976-997.
[5]	Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of atopic dermatitis in the elderly （2023） [J]. Chinese Journal of Dermatology, 2023, 56(11): 991-999.
[6]	Consensus Workgroup on Herpes Zoster, China Dermatologist Association, National Clinical Research Center for Skin and Immune Diseases. Chinese consensus on the diagnosis and management of herpes zoster （2022） [J]. Chinese Journal of Dermatology, 2022, 55(12): 1033-1040.
[7]	Chinese Association of Rehabilitation Dermatology, Photodynamic Therapy Research Center, Chinese Society of Dermatology, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Expert consensus on clinical diagnosis and treatment of actinic keratosis in China（2021） [J]. Chinese Journal of Dermatology, 2021, 54(12): 1048-1056.
[8]	Cui Pangen, Liu Xun-quan, Chen Kun. An Analysis of 23 Inpatients with Generalized Pustular Psoriasis in Children [J]. Chinese Journal of Dermatology, 1996, 29(6): 405-407.
[9]	Yao Zhirong, Liao Wanqing, Wen Hai. Treatment of Cryptococcal Meningitis [J]. Chinese Journal of Dermatology, 1996, 29(5): 324-326.

Advances in Hailey-Hailey Disease

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［39］

Related Articles 9

Metrics

Comments

Recommended 10